Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model

Vaccine

Volumn 28, Issue 27, 2010, Pages 4362-4368

  Komatsu, Eiji ^a   Yamaguchi, Fuminori ^a   Eguchi, Masahiro ^b   Watanabe, Mineo ^b  

^a KITASATO INSTITUTE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Bordetella parapertussis; Bordetella pertussis; Pertussis vaccine

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; BORDETELLA PARAPERTUSSIS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DTAP; HEMAGGLUTININ; PERTUSSIS VACCINE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; WHOLE CELL VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BORDETELLA PARAPERTUSSIS; BORDETELLA PARAPERTUSSIS INFECTION; BORDETELLA PERTUSSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PERTUSSIS; PREVALENCE; PRIORITY JOURNAL; SINGLE DRUG DOSE; VACCINE PRODUCTION; WHOLE CELL;

AGGLUTINATION TESTS; ANIMALS; BLOTTING, WESTERN; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; FEMALE; MICE; MICE, INBRED BALB C; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 77952741882     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.053     Document Type: Article

References (22)

1. World_Health_Organization. Pertussis. 2009 [cited 2009/12/1]. Available from: http://www.who.int/immunization_monotoring/diseases/pertussis/en.
2. Bergfors E., Trollfors B., Taranger J., Lagergard T., Sundh V., and Zackrisson G. Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses. Int J Infect Dis 3 3 (1999) 140-146
3. Borska K., and Simkovicova M. Studies on the circulation of Bordetella pertussis and Bordetella parapertussis in populations of children. J Hyg Epidemiol Microbiol Immunol 16 2 (1972) 159-172
4. Mastrantonio P., Giuliano M., Stefanelli P., Sofia T., De Marzi L., Tarabini G., et al. Bordetella parapertussis infections. Dev Biol Stand 89 (1997) 255-259
5. Mastrantonio P., Stefanelli P., Giuliano M., Herrera Rojas Y., Ciofi degli Atti M., Anemona A., et al. Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates. J Clin Microbiol 36 4 (1998) 999-1002
6. Heininger U., Stehr K., Schmitt-Grohe S., Lorenz C., Rost R., Christenson P.D., et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 13 4 (1994) 306-309
7. Liese J.G., Renner C., Stojanov S., and Belohradsky B.H. Clinical and epidemiological picture of Bordetella pertussis and Bordetella parapertussis infections after introduction of acellular pertussis vaccines. Arch Dis Child 88 8 (2003) 684-687
8. Watanabe M., and Nagai M. Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther 2 3 (2004) 447-454
9. Kasuga T., Nakase Y., Ukishima K., and Takatsu K. Studies on Haemophilus pertussis. I. Antigen structure of H. pertussis and its phases. Kitasato Arch Exp Med 26 2-3 (1953) 121-133
10. Kajava A.V., Cheng N., Cleaver R., Kessel M., Simon M.N., Willery E., et al. Beta-helix model for the filamentous haemagglutinin adhesin of Bordetella pertussis and related bacterial secretory proteins. Mol Microbiol 42 2 (2001) 279-292
11. Guiso N., Capiau C., Carletti G., Poolman J., and Hauser P. Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines. Vaccine 17 19 (1999) 2366-2376
12. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 5259 (1970) 680-685
13. Sekiya K., Kawahira M., and Nakase Y. Protection against experimental Bordetella bronchiseptica infection in mice by active immunization with killed vaccine. Infect Immun 41 2 (1983) 598-603
14. Watanabe M., and Nagai M. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Infect Immun 69 11 (2001) 6981-6986
15. Watanabe M., and Nagai M. Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Infect Immun 71 2 (2003) 733-738
16. Wolfe D.N., Goebel E.M., Bjornstad O.N., Restif O., and Harvill E.T. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity. Infect Immun 75 10 (2007) 4972-4979
17. Mielcarek N., Debrie A.S., Raze D., Bertout J., Rouanet C., Younes A.B., et al. Live attenuated Bordetella pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2 7 (2006) e65
18. Piatti G. Identification of immunodominant epitopes in the filamentous hemagglutinin of Bordetella pertussis. FEMS Immunol Med Microbiol 23 3 (1999) 235-241
19. Julio S.M., Inatsuka C.S., Mazar J., Dieterich C., Relman D.A., and Cotter P.A. Natural-host animal models indicate functional interchangeability between the filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchiseptica and reveal a role for the mature C-terminal domain, but not the RGD motif, during infection. Mol Microbiol 71 6 (2009) 1574-1590
20. Khelef N., Danve B., Quentin-Millet M.J., and Guiso N. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun 61 2 (1993) 486-490
21. Colombi D., Horton D.S., Oliveira M.L., Sakauchi M.A., and Ho P.L. Antibodies produced against a fragment of filamentous haemagglutinin (FHA) of Bordetella pertussis are able to inhibit hemagglutination induced by the whole adhesin. FEMS Microbiol Lett 240 1 (2004) 41-47
22. Wilson D.R., Siebers A., and Finlay B.B. Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies. Infect Immun 66 10 (1998) 4884-4894